|
EFIR, AONE, PSID, CBAI, ORS, GRDC
Our Stocks to Watch today include EGPI Firecreek Inc. (OTCBB: EFIR), A123 Systems Inc. (NASDAQ: AONE), PositiveID Corp. (NASDAQ: PSID), Cord Blood America Inc. (OTCBB: CBAI), Orsus Xelent Technologies Inc. (AMEX: ORS) and Grid Cloud Solutions Inc. (OTC: GRDC).
EGPI FIRECREEK INCORPORATED (OTCBB: EFIR)
"Up 53.46% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/EFIR.php
EGPI Firecreek, Inc.'s business and acquisition strategy is focused on both the vertical integration of enterprises serving the DOT Construction and Intelligent Traffic System markets alongside its wholly owned subsidiary M3, Lighting, Inc. (M3), and on oil and gas production with an emphasis on acquiring existing fields with proven reserves, the rehabilitation of potentially high throughput oilfields, resource properties and inventories, through its wholly owned subsidiary Energy Producers, Inc. (Energy Producers). EGPI Firecreek, Inc. is also looking to expand into Alternative energy sources as well as industries in the energy field. Other companies in the oil sector include Exxon Mobil, Pantina Oil and Gas Inc., Frontier Oil Inc. and Cabot Oil & Gas Inc.
EFIR News:
July 19 - EGPI Firecreek Inc. Completes Agreement to Acquire Caddo International
EGPI Firecreek, Inc. (OTCBB: EFIR) (the “Company”) announced it has completed an agreement for the acquisition of Caddo International, Inc., a Nevada corporation ("Caddo").
The Agreement for the Caddo acquisition is subject to the completion of all required SEC filings and shall be structured as a share exchange, based on independent third party valuations of the two entities, and all requirements for the audited financials of Caddo, which shall be completed prior to the closing. The expected time for completion is 90 days. Currently, the acquisition has 67% support from the existing shareholders of Caddo.
As previously reported, Caddo International has been in business for over 40 years as an oil production and service company, utilizing their own equipment and pulling units, in order to provide oilfield services. The company currently produces revenues of approximately $1.4 million to $2.4 million dollars per year with an estimated $6 million dollars in assets.
Caddo also provides oil field services to several oil and gas company operators including several hundred wells in the Caddo Pine Island field, the Haynesville field and the Desoto Parish known as the Spyder field.
A123 SYSTEMS INCORPORATED (NASDAQ: AONE)
"Up 45.11% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/AONE.php
A123 Systems, Inc., together with its subsidiaries, engages in the design, development, manufacture, and sale of rechargeable lithium-ion batteries and battery systems primarily in the United States. Its batteries and battery systems are based on its Nanophosphate technology for application development in the transportation, electric grid services, and consumer markets. The company also offers its products worldwide. It has a joint venture with SAIC Motor Co. Ltd. to develop, manufacture, and sell complete vehicle traction battery systems for use in hybrid electric vehicles, and electric vehicles in China. The company was founded in 2001 and is headquartered in Watertown, Massachusetts.
AONE News:
August 11 - Reuters Reports General Motors Co. Awards A123 Systems Inc. Contract to Build Battery Packs
Reuters reports that A123 Systems Inc. (NASDAQ: AONE) has identified GM as the "major North American automaker" that was referenced in an earlier briefing. For more information, visit http://reut.rs/p4eWa6.
POSITIVEID CORPORATION (NASDAQ: PSID)
"Up 24.37% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/PSID.php
PositiveID Corporation develops and markets healthcare and information management products through its RFID-based diagnostic devices and identification technologies, and its proprietary disease management tools. PositiveID operates in two main divisions: HealthID and ID Security.
PSID News:
August 11 - U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study
DHS' Science and Technologies Division Confirms Performance of the PSIDMBA
PositiveID Corporation (Nasdaq: PSID) ("PositiveID" or "Company"), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced that the Department of Homeland Security ("DHS") Science and Technologies division has validated the performance of the Company's recently launched Multiplex BioThreat Assay ("MBA"), the PSIDMBA, through an in-house blind study. This validation was performed under the direction of and funded by DHS S&T. The PSIDMBA, available at www.psidmba.com, is the first commercially available MBA for the detection of up to six bio-threat organisms on the Centers for Disease Control & Prevention ("CDC") Category A and B lists. The PSIDMBA was developed and perfected over a five-year period by MicroFluidic Systems ("MFS"), the Company's wholly owned subsidiary.
The PSIDMBA tests for the following six organisms with 16 organism specific signatures: Bacillus anthracis (Anthrax); Yersinia pestis (Plague); Francisella tularensis (Tularemia); Burkholderia pseudomallei (Melioidosis); Burkholderia mallei (Glanders); and Variola major* (Small Pox). The PSIDMBA is also fully customizable to meet specific customer needs, and is the first in a series of environmental and food pathogen assays expected to be available.
Intended for investigative and research use, the PSIDMBA offers rapid, accurate and efficient multiple organism identification in a cost-effective manner. Currently available methods require up to 16 times more sample, are more costly per signature and are not amenable to high-throughput analyses. The PSIDMBA assay is designed to provide test results for up to six organisms in the time of a single polymerase chain reaction (i.e. 30 to 90 minutes), versus the several hours or more required to test multiple samples with conventional methods. A blind assay validation study was successfully completed through DHS with more than 150 competing natural occurring strains, near-neighbors, and environmental samples. Samples were tested in triplicate with 100% agreement being achieved for all positives and negatives at a limit of detection which is equivalent or better than similar assays performed in a singleplex format. Further, the PSIDMBA was evaluated in real condition environments in a major east coast U.S. city for a period of one year without any false positive results. The ease of use and data interpretation makes the PSIDMBA suitable for a broad range of settings such as environmental monitoring, clinical, agricultural and veterinary settings.
The PSIDMBA kit provides added specificity and selectivity by using a total of 16 genomic and plasmid specific signatures to confirm the presence or absence of a strain specific organism. The proprietary multicolor combinatorial approach allows a user to rapidly screen a biological sample for the presence of five bacteria and one virus in only three simultaneous reactions, whereas a traditional singleplex method would require at least 16 reactions to accomplish the identical task. An additional benefit of the multiplex kit is a significant reduction in cost per test when compared to running the samples in a singleplex format.
Mr. Lyle Probst, Senior Director of Programs at MFS, and co-developer of the assay said, "Having worked in the field of biodefense and assay development for the last 10 years, I believe the PSIDMBA achieves better performance and higher cost savings than any other assay currently on the market. In order to assess the assay's ability to detect unknown samples, our team challenged it in triplicate against a series of blind samples provided by DHS. Our results indicate that the multiplex assay was strain specific and produced no false positives or negatives when challenged with in house gDNA collections and DHS provided panels. Also, these results were achieved with a limit of detection that is state-of-the-art and equivalent or better than those achieved with in singleplex fashion."
CORD BLOOD AMERICA INCORPORATED (OTCBB: CBAI)
"Up 15.48% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/CBAI.php
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.
CBAI News:
August 11 - NeoStem and Cord Blood America Look to Make Splash in Stem Cell Market
The Bedford Report Provides Equity Research on NeoStem and Cord Blood America
With Americans spending in excess of $300 billion annually on drugs which typically only treat disease symptoms, regenerative therapies are garnering increased support. Scientists argue that stem cells are the future of healthcare, and that regenerative medicine is one of the most misunderstood fields in biotechnology. The Bedford Report examines the outlook for companies in the Biotechnology Industry and provides investment research on NeoStem, Inc. (AMEX: NBS) and Cord Blood America, Inc. (OTCBB: CBAI). Access to the full company reports can be found at:
www.bedfordreport.com/NBS
www.bedfordreport.com/CBAI
Embryonic stems cell research suffers on-again, off-again bans on US federal funding. Since Obama took office, funding has been less sporadic. Earlier this spring a US appeals court ruled that the Obama administration can continue using federal tax dollars to fund human embryonic stem cell research.
Headlines regarding the funding (or lack thereof) for embryonic stem cell research have a habit of moving all stem cell related stocks, even those not involved in the controversial sector. Very few publicly traded companies are actually engaged in embryonic stem cell research.
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Earlier this summer the company acquired the assets of NeoCells, a subsidiary of ViviCells International, Inc., Evanston, Illinois, through a foreclosure procedure at a purchase price of $320,000.
NeoStem also holds the worldwide exclusive license to VSEL Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use.
The Bedford Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. The full disclaimer is at www.bedfordreport.com/disclaimer.
ORSUS XELENT TECHNOLGIES INCORPORATED (AMEX: ORS)
"Up 24.24% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/ORS.php
Incorporated in the State of Delaware and headquartered in Beijing, China, Orsus Xelent Technologies, Inc. is an emerging designer and manufacturer of award-winning mobile phones for the Asian market, primarily the People's Republic of China ("PRC"). The Company's business encompasses the design of mobile phones, related digital circuits, and software development, and it is a recognized pioneer in mobile phone integration technology. It introduced the region's first wristwatch-style cellular phone, and it continues to break new ground with state-of-the-art phones that include advanced features such as fingerprint recognition and touch-screen displays. The Company also is focused on developing and marketing, under its Proxlink trademark, special application mobile phones for specialized users in a wide variety of professions in business and government. Since the Company's launch in 2004, it has established "Orsus" as a popular brand and achieved a significant share of the world's largest mobile phone market. It maintains more than 179 service call centers across the PRC, with additional offices in Shanghai, Hong Kong, Shenzhen, and Tianjin.
ORS News:
July 20 - Orsus Xelent Notified It Is Subject to Delisting on the NYSE Amex and Is Pursuing an Appeal to the Exchange
Orsus Xelent Technologies, Inc. (AMEX: ORS) ("Orsus" or the "Company") reported today that on July 14, 2011 the Company received a letter from the NYSE Amex LLC (the "Exchange") staff indicating it is no longer in compliance with the Exchange's continued listing standards as described below and its securities are therefore subject to being delisted from the Exchange. In response to this, the Company said it is taking the steps necessary to request a hearing before a committee of the Exchange to appeal the staff determination.
The notification from the Exchange indicated the Company was not in compliance with Section 1003(a)(iv) of the Exchange's Company Guide with respect to its financial condition, which makes it questionable in the opinion of the Exchange as to whether the Company will be able to continue operations or timely meet its obligations.
The Company previously submitted a plan on May 23, 2011 to the Exchange advising the Exchange of actions it had taken or would take to regain compliance, and had supplemented its plan with additional letters as recently as July 1, 2011. After review of the plan and the supplemental letters the Exchange determined the Company did not make a reasonable demonstration of its ability to regain compliance with Section 1003(a)(iv) by July 21, 2011.
The Company said it believes it is in the best interests of the Company and its shareholders to maintain a listing on the NYSE Amex and therefore is pursuing an appeal, although there is no assurance it will be successful.
GRID CLOUD SOLUTIONS INCORPORATED (OTC: GRDC)
"Up 25.00% on Thursday"
Detailed Quote: http://www.otcpicks.com/quotes/GRDC.php
Grid Cloud Solutions Inc. offers comprehensive design, development and management services to the Biomass, Solar Thermal & PV and Wind energy industry. The Company brings decades of energy consulting experience to the marketplace. Management's approach is based at rapid growth through partnerships, mergers and acquisitions using the principals' connectivity in the marketplace.
GRDC News:
August 11 - Grid Cloud Solutions Updates Shareholders: Expands Services to 3 Canadian Provinces and 5 More Countries
Grid Cloud Solutions Inc. (OTC: GRDC) updated investors on its recent business development progress. Since March 2011, GRDC has pursued several business lines in the renewable energy sector, aiming at companies, communities, cooperatives and individuals looking for cost-effective energy solutions in the fields of energy conservation, green energy generation or energy efficient housing systems.
GRDC's CEO Danny Wong: "We realize that in a period of economic recession, many of our customers and partners are in need of significant energy cost savings. Our business model is to provide proven solutions and services with fast payback and we are pleased that our approach has permitted us to grow our business lines for significant short term profits despite the current economic uncertainty."
GRDC is in the advanced stages of negotiations for providing HVAC procurement services for 3 of its clients. The opportunity is for housing developments which number in excess of 150 buildings. All projects are expected to be under construction within 60 days.
Using the service models developed in Ontario, the company has begun offering its services in 3 more Canadian provinces (Manitoba, Quebec, and New Brunswick) and 5 more countries (Jamaica, Republic of the Congo (Congo-Brazzaville), Democratic Republic of the Congo (Congo-Brazzaville) and Nigeria). The cost of power in Africa, either through distribution grids or through home operated diesel generators offers an excellent opportunity for home solar power.
GRDC continues exploring strategic alliances and marketing rights for renewable energy and conservation technologies. In the last quarter, the company began the sales and marketing of patented insulated panel, for building systems, for one of its clients. The initial agreement was on a trial basis but provided GRDC with consulting and sales revenues. An exclusive long term sales and marketing contract is currently under negotiations and will be disclosed to investors once completed.
GRDC continues to pursue a number of leads for the Engineering Procurement and Contracting of photovoltaic projects. The company has received purchase orders for two projects which are now expecting final connection approval from authorities shortly. GRDC is also in advanced stages of negotiations for providing EPC services for 5 more projects with additional projects already in the queue. Still in Ontario, the company has secured a number of options for the development of ground mounted solar power projects totalling an excess of 30 MW of power. Related to these projects, the company has entered into Memorandums of Understanding for their financing, contingent on such projects securing Power Purchase Agreements.
Grid Cloud Solutions Inc. offers comprehensive design, development and management services to the Biomass, Solar Thermal & PV and Wind energy industry. The Company brings decades of energy consulting experience to the marketplace. Management's approach is based on rapid growth through partnerships, mergers and acquisitions using the principals' connectivity in the marketplace.
|
